Executives On The Move

Recent executive moves in the industry include new C-suite hires at Editas Medicines, Royalty Pharma and Faron Pharmaceuticals.  

Recent executive moves in the industry include new CEOs at Rentschler Biopharma, MedinCell and OncoZenge, plus C-suite changes at Hinova Pharmaceuticals and ImmunoGen.

The UK-based company has replaced its single head of research with four therapy area-focused leaders as it looks to further boost R&D productivity.

Recent executive moves in the industry include new CEOs at Baxter BioPharma Solutions, Destiny Pharma and PAION, while Medicenna Therapeutics, Mirum Pharmaceuticals and Scancell, among others, get new CFOs. 

In this week's podcast edition of Five Must-Know Things: the rise of Novo Nordisk; senior level changes at Novartis; Moderna’s progress against BA.2.86; major new CNS drugs coming; and Boehringer Ingelheim’s head of innovation on R&D priorities.

Recent executive moves in the industry include C-suite changes at Abivax, Innoviva and VistaGen Therapeutics, plus a new CMO at Exelixis.

Recent executive moves in the industry include C-suite changes at PaxMedica and Amicus Therapeutics. Meanwhile, new directors were appointed at Aurinia Pharmaceutical and Skye Bioscience.

Recent executive moves in the industry include C-suite changes at Eterna Therapeutics and PaxMedica. Meanwhile, new directors were appointed at Syncom Formulation and Soleno Therapeutics.

Recent executive moves in the industry include C-suite changes at Mirati Therapeutics, Spero Therapeutics and Verastem. Meanwhile, new directors were appointed at Xenon Pharmaceuticals, MediciNova and Allarity Therapeutics. 

Private equity firms are among those believed to be in the fray for a stake in India's Cipla, a company with a rich legacy and steeped in history. It’s an ideal case study for buyout funds, an investment banker tells Scrip.

Recent executive moves in the industry include C-suite changes at GreenLight Biosciences Holdings and TScan Therapeutics. Meanwhile, new directors were appointed at AEON Biopharma and Kiromic Biopharma.

Recent executive moves in the industry include C-suite changes at Amarin, Shanghai Henlius Biotech and Futura Medical. Meanwhile, new directors were appointed at AI Therapeutics and Arbutus Biopharma.

Recent executive moves in the industry include C-suite changes at BioCryst Pharmaceuticals and CytoDyn. Meanwhile, new directors were appointed at Abivax and Eterna Therapeutics.

Recent executive moves in the industry include C-suite changes at Bionomics and Kancera. Meanwhile, new directors were appointed at Kineta and NLS Pharmaceuticals.

Recent executive moves in the industry include C-suite changes at Windtree Therapeutics and Ferring, plus new board members at Acorda Therapeutics and Mirati Therapeutics.

Recent executive moves in the industry include C-suite changes at Everest Medicines, Pharnext and Cerevel Therapeutics, plus new board members at Arvinas and Prometheus Biosciences.